Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NSE/TAKE stock hub

NSE/TAKE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/TAKEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.9B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/TAKE

In the news

Latest news · NSE/TAKE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/En/a

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC-14.8

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/TAKE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

139

Groups with data

Currency

INR

Showing 139 of 139 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	2
Employees Change	-201%
Employees Change Percent	-99.01
Enterprise value	INR 4.9B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Biotechnology
Isin	INE142I01023
Last refreshed	2026-05-10
Market cap	INR 4.9B
Price	INR 33.06
Price currency	INR
Sector	Healthcare
Sic	7370
Symbol	nse/TAKE
Website	https://www.takesolutions.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0%
EV Earnings	-232,818.95x
P/B ratio	19.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	INR -6.1M
Net Income	INR -21,000
Net Income Growth Q	-97.67%
Net Income Growth Years	1%
Profit Per Employee	INR -10,500
Profitable Years	1
Roa5y	-5.4
Roe5y	-39.8
ROIC	-14.8
Roic5y	-18.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-12.6%
Cagr15y	0.23%
Cagr1y	339.49%
Cagr3y	19.54%
Cagr5y	-10.15%
Div CAGR10	0%
EPS Growth Q	-97.85
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 1.5M
Equity	INR 256.3M
Interest Coverage	-6.36
Net Cash	INR 1.5M
Net Cash By Market Cap	INR 0.03
Net Debt Equity	INR -0.01
Tangible Book Value	INR 256.3M
Tangible Book Value Per Share	INR 1.75
WACC	7.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	20.4%
Dividend per share	INR 0
Last Dividend	INR 0.4

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-73.99%
1Y total return	339.04%
200-day SMA	29.25
3Y total return	70.85%
50-day SMA	41.91
50-day SMA vs 200-day SMA	50over200
5Y total return	-41.43%
All Time High	308.3
All Time High Change	-89.27%
All Time High Date	2018-06-15
All Time Low	6.51
All Time Low Change	407.83%
All Time Low Date	2025-04-01
ATR	1.31
Beta	0.54
Beta1y	1.25
Beta2y	1.17
Ch YTD	-17.23
High	33.06
High52	50.14
High52 Date	2026-04-20
High52ch	-34.06%
Low	33.06
Low52	7.3
Low52 Date	2025-05-09
Low52ch	352.88%
Ma50ch	-21.11%
Price vs 200-day SMA	13.02%
RSI	22.47
RSI Monthly	57.67
RSI Weekly	47.01
Sharpe ratio	3.13x
Sortino ratio	5.51
Total Return	20.4%
Tr YTD	-17.23
Tr15y	3.56%
Tr1m	-22.88%
Tr1w	-18.49%
Tr3m	-23.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -37.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	73,280,007%
Shares Insiders	0.16%
Shares Out	147,934,000
Shares Qo Q	8.32%
Shares Yo Y	-20.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	637,357x
Bv Per Share	1.75
Ch10y	-74.7
Ch15y	-12.31
Ch1m	-22.88
Ch1w	-18.49
Ch1y	339
Ch3m	-23.6
Ch3y	70.85
Ch5y	-41.43
Ch6m	46.22
Change	-4.97%
Change From Open	0
Close	34.79
Days Gap	-4.97
Depreciation Amortization	-28,400,000
Dollar Volume	2,138,221.6
Earnings Date	2026-05-29
EBIT	INR -37.7M
EBITDA	INR -66.1M
EPS	INR -0
F Score	0
Fiscal Year End	March
Founded	2,000
Income Tax	INR 1.6M
Is Primary Listing	1
Last Earnings Date	2026-02-14
Last Report Date	2025-12-31
Last Split Date	2008-09-18
Last Split Type	Forward
Ma150	35.56
Ma150ch	-7.04%
Ma20	44.08
Ma20ch	-25%
Next Earnings Date	2026-05-29
Open	33.06
Price Date	2026-05-08
Ptbv Ratio	19.09
Relative Volume	0.1x
Tr6m	46.22%
Volume	64,677

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/TAKE pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/TAKE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/TAKE?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-20.4%

Negative means the company is buying back shares.

Technical

NSE/TAKE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

22.5

Below 30: short-term oversold

Price vs 200-day MA

+13.0%

50/200-day relationship not available

Beta (5Y)

0.54

Less volatile than the market

Sharpe ratio

3.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/TAKE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/TAKE stock rating?

nse/TAKE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/TAKE analysis?

The full report lives at /stocks/nse/TAKE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/TAKE?

The latest report frames nse/TAKE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/TAKE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.